TRIN 📈 Trinity Capital - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8964423086
TRIN: Venture Debt, Equipment Financing, Term Loans, Equity Investments
Trinity Capital Inc. is a business development company that takes a unique approach to investing in innovative medical devices and growth-stage companies. By providing venture debt, loans, and equipment financing, the firm helps businesses scale and achieve their goals.
Trinity Capital's investment strategy is designed to generate consistent income, with a secondary focus on long-term capital appreciation. To achieve this, the company makes term loans and equity-related investments in its portfolio companies, providing a stable source of returns for its investors.
Headquartered in Phoenix, Arizona, Trinity Capital has a strong presence in the United States, with additional offices strategically located throughout the country. This allows the firm to stay close to its portfolio companies and provide hands-on support when needed.
Since its founding in 2019, Trinity Capital has established itself as a trusted partner for innovative companies looking to drive growth and expansion. With a focus on medical devices and growth-stage businesses, the firm is well-positioned to capitalize on emerging trends and opportunities in these sectors.
For more information about Trinity Capital Inc., please visit their website at https://www.trinitycap.com.
Additional Sources for TRIN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TRIN Stock Overview
| Market Cap in USD | 845m |
| Sector | Financial Services |
| Industry | Asset Management |
| GiC Industry | Capital Markets |
| TER | 0.00% |
| IPO / Inception | 2021-01-29 |
TRIN Stock Ratings
| Growth 5y | 61.3% |
| Fundamental | 38.3% |
| Dividend | 88.4% |
| Rel. Performance Sector | -2.36 |
| Analysts | 4.5/5 |
| Fair Price Momentum | 15.68 USD |
| Fair Price DCF | 24.50 USD |
TRIN Dividends
| Dividend Yield 12m | 14.10% |
| Yield on Cost 5y | 22.33% |
| Annual Growth 5y | 17.32% |
| Payout Consistency | 95.78% |
TRIN Growth Ratios
| Growth Correlation 3m | 77.8% |
| Growth Correlation 12m | 69% |
| Growth Correlation 5y | 77.8% |
| CAGR 5y | 12.65% |
| CAGR/Mean DD 5y | 1.21 |
| Sharpe Ratio 12m | 0.50 |
| Alpha | -16.05 |
| Beta | 0.76 |
| Volatility | 17.68% |
| Current Volume | 346.8k |
| Average Volume 20d | 453.5k |
As of December 05, 2024, the stock is trading at USD 14.40 with a total of 346,825 shares traded.
Over the past week, the price has changed by -0.55%, over one month by +9.84%, over three months by +6.46% and over the past year by +12.35%.
Partly, yes. Based on ValueRay Fundamental Analyses, Trinity Capital (NASDAQ:TRIN) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.29 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRIN as of December 2024 is 15.68. This means that TRIN is currently overvalued and has a potential downside of 8.89%.
Trinity Capital has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy TRIN.
- Strong Buy: 6
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TRIN Trinity Capital will be worth about 17.5 in December 2025. The stock is currently trading at 14.40. This means that the stock has a potential upside of +21.81%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 15.5 | 7.6% |
| Analysts Target Price | 15.6 | 8.1% |
| ValueRay Target Price | 17.5 | 21.8% |